Lgr5蛋白激活树突状细胞诱导抗原特异性细胞毒T淋巴细胞治疗结肠癌的实验

doi:10.16098/j.issn.0529-1356.2017.04.010

解剖学报 ›› 2017, Vol. 48 ›› Issue (4): 428-433.doi: 10.16098/j.issn.0529-1356.2017.04.010

Lgr5蛋白激活树突状细胞诱导抗原特异性细胞毒T淋巴细胞治疗结肠癌的实验

马刚^1,2 杨庆强^1* 何兴状³

1.西南医科大学第一附属医院胃肠外科，四川泸州 646000; 2.广元市第一人民医院普外科，四川广元 628017; 3.广元市第一人民医院病理科，四川广元 628017

收稿日期:2016-11-24 修回日期:2016-12-15 出版日期:2017-08-06 发布日期:2017-08-06
通讯作者: 杨庆强 E-mail:magang283@163.com

Experimental immunotherapy study on colon cancer by lgr5 activated dendritic cells to induce antigen-specific CD8+ cytotoxic T lymphocytes

MA Gang^1,2 YANG Qing-qiang^1* HE Xing-zhuang³

1.Department of Gastrointestinal Surgery, the First Affiliated Hospital of Southwest Medical University, Sichuan Luzhou 646000, China; 2.Department of General Surgery, Guangyuan First People’s Hospital, Sichuan Guangyuan 628017, China; 3.Department of Pathology, Guangyuan First People’s Hospital, Sichuan Guangyuan 628017, China

Received:2016-11-24 Revised:2016-12-15 Online:2017-08-06 Published:2017-08-06
Contact: YANG Qing-qiang E-mail:magang283@163.com

摘要/Abstract

摘要：

目的探讨富含亮氨酸重复序列的G蛋白耦联受体5(Lgr5）蛋白激活树突状细胞(DCs),诱导产生CD8+ 细胞毒T淋巴细胞（CTL）进行结肠癌免疫治疗的效果。方法利用Lgr5蛋白诱导DCs成熟，同时检测DCs表面标记物和白细胞介素（IL)-10与IL-12表达量的变化，随后通过Lgr5-DC诱导Lgr5抗原特异性CD8⁺ CTL，并检测Lgr5-DC-CD8⁺ CTL对正常结肠上皮细胞CCD-18Co和结肠癌细胞HT29的作用，同时检测干扰素（IFN）-γ释放量。然后进一步检测Lgr5-DC-CD8⁺ CTL对BALB/C-nu/nu小鼠结肠癌的抑制情况，并通过组织染色观察治疗后肿瘤组织的变化。结果与PBS刺激相比，Lgr5蛋白刺激能够显著上调DCs表面标记物DC80、DC83、DC86和HLA-DR水平，依次达到3.29、3.06、2.90和6.93倍；同时Lgr5蛋白刺激显著促进IL-12的释放和显著减少IL-10的分泌(P＜0.05)。Lgr5-DC-CD8⁺ CTL和DC-CD8⁺ CTL均导致少量CCD-18Co细胞杀伤(P＞0.05)，而Lgr5-DC-CD8⁺ CTL对HT29细胞的杀伤率是DC-CD8+ CTL的4.40倍(P＜0.05)。动物实验表明，BALB/C-nu/nu结肠癌移植鼠经Lgr5-DC-CD8⁺CTL治疗后，肿瘤体积比显著低于PBS组和DC-CD8⁺CTL组，依次达到0.25和0.24倍(P＜0.05)。组织染色显示 Lgr5-DC-CD8⁺CTL处理导致明显的肿瘤组织病理学改变，同时BAX表达升高。结论 Lgr5蛋白促进DCs成熟并诱导产生Lgr5抗原特异性CD8⁺ CTL，Lgr5-DC-CD8⁺ CTL能够高效的杀伤肿瘤细胞并延迟肿瘤生长。

关键词: 富含壳氨酸重复序列的G蛋白耦联受体, 树突状细胞, 细胞毒T淋巴细胞, 结肠癌, 免疫治疗, 小鼠

Abstract:

Objective To observe the immunotherapy effect on colon cancer by leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) activated by dexxeperimental basis for colon cancer immunotherapy. Methods After dendritic cells (DCs) maturation induced by Lgr5, surface molecules, interleukin (IL)-12, and IL-10 of DCs were detected. Subsequently, Lgr5 antigen specific CD8⁺ cytotoxic T lymphocyte (CTL) was induced by Lgr5-DC. The killing effect and interferon (IFN)-γ of Lgr5-DC-CD8⁺ CTL on normal colonic epithelial cells CCD-18Co and colon cancer cell HT29 were tested. After Lgr5-DC-CD8+ CTL treatment, tumor volume in BALB/C-nu/nu mice was detected. The morphology of tumor tissue after treatment was observed by tissue staining. Results Compared with PBS, Lgr5 protein stimulation significantly increased surface markers DC80, DC83, DC86 and HLA-DR levels, and up to 3.29, 3.06, 2.90 and 6.93 times (P＜0.05)respectively. Lgr5 stimulation significantly stimulated the release of IL-12 and significantly reduced the secretion of IL-10 (P＜0.05). DC-CD8⁺ CTL and Lgr5-DC-CD8⁺CTL. Both resulted in a small amount of CCD-18Co cell killing (P＞0.05), but the killing rate of Lgr5-DC-CD8⁺ CTL on HT29 cells was 4.40 times as much as that of DC-CD8⁺ CTL. Tissue staining showed that Lgr5-DC-CD8⁺ CTL treatment resulted in significant pathological changes and BAX expression in tumor tissues. Conclusion Lgr5 protein stimulated the maturation of DCs cells that induced the production of Lgr5 antigen specific CD8⁺ CTL. Lgr5-DC-CD8⁺ CTL can effectively kill tumor cells and delay the growth of tumor.

Key words:

Leucine-rich repeat-containing G-protein collpled receptor 5, Dendritic cell, Cytotoxic T lymphocyte, Colon cancer, Immunotherapy, Mouse

马刚杨庆强何兴状. Lgr5蛋白激活树突状细胞诱导抗原特异性细胞毒T淋巴细胞治疗结肠癌的实验[J]. 解剖学报, 2017, 48(4): 428-433.

MA Gang YANG Qing-qiang HE Xing-zhuang. Experimental immunotherapy study on colon cancer by lgr5 activated dendritic cells to induce antigen-specific CD8+ cytotoxic T lymphocytes[J]. Acta Anatomica Sinica, 2017, 48(4): 428-433.

参考文献

［1］Zhang YX, Zhao HJ, Song WG, et al. Effects of TWEAK antisense oligonucleotide on the proliferation and invasion of human colon cancer cell line SW480［J］. Acta Anatomica Sinica, 2014,45 (1): 74-79. (in Chinese)

张延新,赵红军,宋文刚,等.TWEAK反义寡核苷酸对人结肠癌细胞系SW480增殖及侵袭能力的影响［J］.解剖学报,2014,45(1):74-79.

［2］Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy［J］. Science, 2015, 348(6230):69-74.

［3］Mahoney KM, Rennert PD, Freeman GJ. Combination cancer immunotherapy and new immunomodulatory targets［J］. Nat rev Drug Discov, 2015,14(8):561-584.

［4］Sigal M, Rothenberg ME, Logan CY, et al. Helicobacter pylori activates and expands Lgr5(+) stem cells through direct colonization of the gastric glands［J］. Gastroenterology, 2015, 148(7):1392-1404.

［5］Ishiguro M, Watanabe T, Kotake K, et al. Japanese Society for Cancer of the Colon and Rectum Guidelines 2010 for the treatment of colorectal cancer: comparison with western guidelines［J］. Invest New Drug, 2016,2(2):179-190.

［6］Sanmamed MF, Pastor F, Rodriguez A, et al. Agonists of co-stimulation in cancer immunotherapy directed against CD137, OX40, GITR, CD27, CD28, and ICOS［J］. Semin Oncol, 2015,42(4):640-655.

［7］Gajewski TF. The next hurdle in cancer immunotherapy: overcoming the non-T-cell-inflamed tumor microenvironment［J］. Semin Oncol, 2015,42(4):663-671.

［8］Ohaegbulam KC, Assal A, Lazarmolnar E, et al. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway［J］. Trends Mol Med, 2015,21(1):24-33.

［9] Gregorieff A, Liu Y, Inanlou MR, et al. Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer［J］. Nature, 2015,526(7575):715-718.

［10］Lei ZJ, Wang J, Xiao HL, et al. Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling［J］. Oncogene, 2015,34(24):3188-3198.

［11］Rimoldi M, Chieppa M, Salucci V, et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells［J］. Nat Immunol, 2015,16(3): 171-198.

［12］Grujic M, Bartholdy C, Remy M, et al. The role of CD80/CD86 in generation and maintenance of functional virusspecific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus［J］. CR Biol, 2015,338(5):335-342.

［13］Alfirevic A, Vilar FJ, Alsbou M, et al. TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole［J］. Pharmacogenomics, 2016,10(4):531-540.

［14］Teng MWL, Bowman EP, Mcelwee JJ, et al. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases［J］. Nat Med, 2015,21(7):719-729.

［15］Chakrabarty P, Li A, Ceballos-piaz C, et al. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior［J］. Neuron, 2015,85(3):519-533.

［16］de Groen RA, Boltjes A, Hou J,et al. IFN-λ-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells［J］. Eur J Immunol, 2015,45(1):250-259.

［17］Yin YX, Xu YQ, Li HL, et al. Expression and significance of IL-1，IL-6， TNF-α and IFN-γ in serum and colon tissue in the rat models of ulcerative colitis with spleen and kidney yang deficiency［J］. Acta Laboratorium Animalis Scientia Sinica, 2015,23(2):139-142. (in Chinese)

殷银霞, 许雅清, 李海龙,等. IL-1、IL-6、TNF-α及 IFN-γ在脾肾阳虚型溃疡性结肠炎模型大鼠血清及组织中的表达［J］. 中国实验动物学报, 2015,23(2):139-142.

［18］Bai L, Takeshima SN, Isogai E, et al. Novel CD8(+) cytotoxic T cell epitopes in bovine leukemia virus with cattle［J］. Vaccine, 2015,33(51):7194-7202.

［19］Noble A, Mehta H, Lovell A, et al. IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8+ T cells ［J］. Eur J Immunol, 2016,46(6):1438-1448.［20］Zhang RQ, Chen ZhL, Luo QH. Enhancing effect of astragalus polysaccharide on the immune function incytoxan-induced immunosuppressed mice［J］. Acta Laboratorium Amomalis Scientia Sinica, 2015,23(4):389-394. (in Chinese)

张芮琪, 陈正礼, 罗启慧. 黄芪多糖干预环磷酰胺所致免疫抑制小鼠的免疫功能［J］. 中国实验动物学报, 2015,23(4):389-394.

[1]	洪晓敏李三强崔钦奕郑润月杨孟利罗仁利李前辉 . 酒精性肝纤维化核因子κB信号通路与性别的差异 [J]. 解剖学报, 2024, 55(1): 55-61.
[2]	袁蕾杨智伟杨惠刘政海何洁万炜. 三七总皂苷抑制小鼠星形胶质细胞活化缓解完全弗氏佐剂所致炎性痛 [J]. 解剖学报, 2024, 55(1): 25-31.
[3]	马婷婷陈建红刘爱翠李海宁. 抑制lncRNA TUG1下调核苷酸结合寡聚结构域样受体蛋白1炎症小体在延缓阿尔茨海默病进展的作用 [J]. 解剖学报, 2024, 55(1): 32-42.
[4]	邹成功冯浩陈兵唐辉邵川孙谋杨荣何家全. 创伤性颅脑损伤中神经功能障碍与认知功能损伤的动态变化 [J]. 解剖学报, 2024, 55(1): 43-48.
[5]	张琴杨俊霞蒋青松. 福辛普利对糖尿病视网膜病变小鼠血管紧张素转化酶2和血管内皮生长因子的影响[J]. 解剖学报, 2023, 54(6): 628-634.
[6]	陈子璇司丽娜舒薇菡张欣魏晨阳程露阳杨松鹤乔跃兵. 褪黑素调控下丘脑PI3K/Akt/mTOR信号延缓雌性小鼠青春期启动的机制 [J]. 解剖学报, 2023, 54(6): 644-651.
[7]	刘哲川李坤马帅男孟家琪王艳芹. 利拉鲁肽对百草枯诱导的小鼠帕金森病模型炎症及线粒体融合/分裂的影响 [J]. 解剖学报, 2023, 54(6): 676-681.
[8]	刘叶楚亚楠徐岑璐何佳澄苏炳银太颢然. Roscovitine挽救帕金森病小鼠相关脑区神经元丢失和神经炎症[J]. 解剖学报, 2023, 54(6): 635-643.
[9]	魏纯纯王平林方兴麻献华章卫平谢志芳 . 小鼠棕色脂肪透射电子显微镜样品固定方法的改良 [J]. 解剖学报, 2023, 54(6): 738-743.
[10]	阎锟武筱林刘英娟葛科立任雷鸣李红云 . 脑蛋白水解物-Ⅰ对帕金森病小鼠肠道菌群的调节作用[J]. 解剖学报, 2023, 54(5): 497-504.
[11]	顾玲张萍宋科昕李娜陈虹宇张婕丛敬翟效月 . 发生发育小鼠肾输尿管芽分支的形态特点[J]. 解剖学报, 2023, 54(5): 593-598.
[12]	何可可李远迪文廷浩朱婕高杰胡蓉韩锋苏敏. 红细胞膜相关蛋白通过IL-6/STAT3/ROR-γt 信号通路抑制小鼠实验性自身免疫性脑脊髓炎中Th17细胞分化[J]. 解剖学报, 2023, 54(5): 538-545.
[13]	范文娟陈旭东陈永芳杨旭光金少举赵志军邓锦波. 体外培养大脑皮质类器官与活体大脑皮质发育的比较[J]. 解剖学报, 2023, 54(4): 383-391.
[14]	张沂洲李莎米世雄左洪春张倩倩李晗琳雷梓晗张东泽崔慧先. 雌二醇经雌激素受体调控分拣蛋白相关受体A对小鼠海马神经元树突棘密度和突触蛋白表达的影响[J]. 解剖学报, 2023, 54(3): 261-268.
[15]	刘柯婷陈缤彬税玉莲石清明肖莉. 外源性H2S对帕金森病模型小鼠神经保护作用及其对基质金属蛋白酶9和Caspase-1表达的影响[J]. 解剖学报, 2023, 54(3): 289-295.

Lgr5蛋白激活树突状细胞诱导抗原特异性细胞毒T淋巴细胞治疗结肠癌的实验

Experimental immunotherapy study on colon cancer by lgr5 activated dendritic cells to induce antigen-specific CD8+ cytotoxic T lymphocytes

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价